Details Remain Unclear as Marijuana Rescheduling Gets Proposed in an Election Year

Details Remain Unclear as Marijuana Rescheduling Gets Proposed in an Election Year

In the months leading up to a presidential election, when there is a chance that the White House may change occupants after November, administrations often push their agendas through federal actions, such as regulations and guidance, coming out of the federal departments.

So, while this election year we are not expecting Congress to get much done in terms of actual legislation, we can expect the Biden Administration to ramp up its efforts at pushing things through at the regulatory level. 

A good example of this is the proposed rule published late last week that would, in essence, make marijuana legal for medicinal use across the country. The rule, coming out of the Drug Enforcement Administration (DEA) under the Department of Justice (DOJ), proposes that marijuana be changed to a Schedule III substance under the Controlled Substances Act.

Marijuana is currently categorized as a Schedule I substance, defined as a substance for which there is a high potential for abuse, no current medical use, and a lack of accepted safety for use, even under medical supervision. 

Last week’s DEA proposed rule follows a determination from the Department of Health and Human Services (HHS) last summer that marijuana in fact does have accepted medical uses, and is less dangerous than other Schedule I drugs, which include heroin and LSD.

This move by the Administration probably triggers more questions than answers, at least with respect to its regulatory challenges. Nearly 40 states have already passed laws that legalize medical use of marijuana, though there is little in the way of state rules on prescriptions, recordkeeping, and other administrative and safety guardrails.

Although the rule would reclassify marijuana, it would still be a controlled substance, which means that federal prosecution is still a risk to anyone who traffics in the drugs or “prescribes” the drugs without the appropriate approvals and processes.

Perhaps just as important as what this proposed rule would do is what the rule would definitely not do. For instance, the proposed rule would not federally legalize marijuana to be grown and sold for recreational use. A total of 24 states allow the sale of recreational cannabis.

As an example of this, the newly proposed rule, if finalized, would not get anyone out of jail who were put there solely for growing or selling marijuana.

Relatedly, the rule would not give the cannabis industry access to credit-card and payment systems.

It is also very unclear what this means for the U.S. drug and healthcare industry at large, as you can well imagine. Could gummies bought at the neighborhood cannabis store now be covered by insurers and bought with your HSAs or FSA?

We are basically at the beginning of what may be a long rulemaking process before the rescheduling actually takes place. However, how long that will take is another question. As you may know, some regulatory changes that have popular support can move quickly from proposed rule to final rule within a year. Other rules can take years. However, we can expect that the Biden Administration will move on this rule quickly.

This may be just the latest in a number of actions that will be taken up this election year by the Biden Administration.

We’ll keep our eyes on it.

Print Friendly, PDF & Email
Facebook
Twitter
LinkedIn

Matthew Albright

Matthew Albright is the chief legislative affairs officer at Zelis Healthcare. Previously, Albright was senior manager at CAQH CORE, and earlier, he was the acting deputy director of the Office of E-Health and Services for the Centers for Medicare & Medicaid Services.

Related Stories

What the End of Chevron Deference May Mean to Us

What the End of Chevron Deference May Mean to Us

During the last week of June, the U.S. Supreme Court unraveled the 1984 decision Chevron v. Natural Resources Defense Council. Chevron has been one of

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Preventing Sepsis Denials: From Recognition to Clinical Validation

Preventing Sepsis Denials: From Recognition to Clinical Validation

ICD10monitor has teamed up with renowned CDI expert Dr. Erica Remer to bring you an exclusive webcast on how to recognize sepsis, how to get providers to give documentation that will support sepsis, and how to educate to avert sepsis denials. Register now and become a crucial piece of the solution to standardizing sepsis clinical practice, documentation, and coding at your facility.

August 22, 2024
Comprehensive Inpatient Clinical Documentation Integrity: From Foundations to Advanced Strategies

Comprehensive Inpatient Clinical Documentation Integrity: From Foundations to Advanced Strategies

Optimize your inpatient clinical documentation and gain comprehensive knowledge from foundational practices to advanced technologies, ensuring improved patient care and organizational and financial success. This webcast bundle provides a holistic approach to CDI, empowering you to implement best practices from the ground up and leverage advanced strategies for superior results. Participants will gain actionable insights to improve documentation quality, patient care, compliance, and financial outcomes.

June 26, 2024
Advanced Inpatient Clinical Documentation Integrity: Harnessing Technology, Analytics, and Compliance

Advanced Inpatient Clinical Documentation Integrity: Harnessing Technology, Analytics, and Compliance

Join expert Angela Comfort, MBA, RHIA, CDIP, CCS, CCS-P., as she helps you navigate advanced inpatient CDI technologies, regulatory changes, and system interoperability. Angela will provide actionable strategies for integrating AI and predictive analytics into CDI practices, ensuring seamless system interoperability, and maintaining compliance with evolving regulations. Attendees will learn to select and implement advanced EHR systems and CDI software, leverage data analytics to enhance documentation accuracy, and stay audit-ready with the latest compliance updates. Real-world case studies and practical tools will empower you to drive continuous improvement in CDI, improve patient outcomes, and enhance organizational efficiency. Don’t miss this opportunity to advance your CDI practices and stay ahead in this dynamic field.

July 11, 2024
Foundations of Inpatient Clinical Documentation Integrity: Enhancing Accuracy and Compliance

Foundations of Inpatient Clinical Documentation Integrity: Enhancing Accuracy and Compliance

Join expert Angela Comfort, MBA, RHIA, CDIP, CCS, CCS-P, for an insightful webcast on improving inpatient clinical documentation integrity (CDI). Inaccurate documentation can lead to misdiagnosis, improper treatment, and compromised patient safety. High workloads, lack of standardized practices, and outdated EHR systems contribute to these issues, affecting care quality and financial outcomes. Angela will offer practical strategies and tools to enhance accuracy, consistency, and timeliness in documentation. Attendees will learn to use standardized templates, checklists, and advanced EHR systems, while staying compliant with regulations. Improve patient care, ensure accurate billing, and reduce audit risks with actionable insights from this essential webcast.

June 26, 2024

Trending News

Featured Webcasts

Pediatric SDoH: An Essential Guide to Accurate Coding and Reporting

Pediatric SDoH: An Essential Guide to Accurate Coding and Reporting

This webcast, presented by Tiffany Ferguson, LMSW, CMAC, ACM, addresses the critical gap in Social Determinants of Health (SDoH) reporting for pediatric populations. While SDoH efforts often focus on adults, this session emphasizes the unique needs of children. Attendees will gain insights into the current state of SDoH, new pediatric Z-codes, and the importance of interdisciplinary collaboration. By understanding and applying pediatric-specific SDoH factors, healthcare professionals can improve data capture, compliance, and care outcomes. This webcast is essential for those looking to enhance their approach to pediatric SDoH reporting and coding.

August 8, 2024
Oncology and E/M Services: Compliance, Medical Necessity, and Reimbursement

Oncology and E/M Services: Compliance, Medical Necessity, and Reimbursement

Join Becky Jacobsen, BSN, RN, MBS, CCS-P, CPC, CPEDC, CBCS, CEMC, VP of CDM, for a webcast addressing oncology service coding challenges. Learn to navigate coding for infusions and injections alongside Evaluation and Management (E/M) services, ensuring compliance and accurate reimbursement. Gain insights into documenting E/M services for oncology patients and determining medical necessity. This webcast is essential to optimize coding practices, maintain compliance, and maximize revenue in oncology care.

July 30, 2024
The Inpatient Admission Order: Master the Who, When, and How

The Inpatient Admission Order: Master the Who, When, and How

During this webcast Dr. Ronald Hirsch delves into the inpatient admission order process including when to get it, when it becomes effective, its impact on billing and payment, who can write it, how to cancel it, the effects on the beneficiary, and more. You’ll leave with a clear understanding of inpatient orders and guidelines for handling improper orders that you can implement immediately.

June 20, 2024
Navigating AI in Healthcare Revenue Cycle: Maximizing Efficiency, Minimizing Risks

Navigating AI in Healthcare Revenue Cycle: Maximizing Efficiency, Minimizing Risks

Michelle Wieczorek explores challenges, strategies, and best practices to AI implementation and ongoing monitoring in the middle revenue cycle through real-world use cases. She addresses critical issues such as the validation of AI algorithms, the importance of human validation in machine learning, and the delineation of responsibilities between buyers and vendors.

May 21, 2024

Trending News

Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →